Frontiers of Materials Science in China

, Volume 2, Issue 4, pp 417–425 | Cite as

Characteristics and degradation of chitosan/cellulose acetate microspheres with different model drugs

Research Article
First Online:
Received:
Accepted:

Abstract

In this study, chitosan/cellulose acetate microspheres (CCAM) were prepared by W/O/W emulsification and solvent evaporation as a drug delivery system. The microspheres were spherical, free-flowing and non-aggregated. The CCAM had good flow and suspension ability. The loading efficiency of different model drugs increased with the increasing hydrophobicity of the drug. The loading efficiency of 6-mercaptopurine (6-MP) was more than 30% whereas that of ranitidine hydrochloride (RT) or acetaminophen (ACP) was only 10%. The pH values of solution affected the swelling ability of CCAM and the relative humidity had little effect on the characteristics of CCAM when it was not more than 75%. The CCAM system had a good effect on the controlled release of different model drugs. However, the release rate became slower with the increase of the hydrophobicity of drugs. The release rate of CCAM loaded with hydrophilic RT was almost 60% during 48 h and the release rate of CCAM loaded with hydrophobic drug of 6-MP was not more than 30%. In the meantime, the CCAM system was degradable in vitro and the degradation rate was faster in lysozyme solution than that in the medium of PBS. So the CCAM system was a degradable promising drug delivery system especially for hydrophobic drugs.

Keywords

chitosan cellulose acetate microspheres characteristic of CCAM 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Agnihotri S A, Aminabhavi T M. Controlled release of clozapine through chitosan microparticles prepared by a novel method. Journal of Controlled Release, 2004, 96(2): 245–259PubMedCrossRefGoogle Scholar
  2. 2.
    Kofuji K, Qian C J, Murata Y, et al. Preparation of chitosan microparticles by water-in-vegetable oil emulsion coalescence technique. Reactive and Functional Polymers, 2005, 62(1): 77–83CrossRefGoogle Scholar
  3. 3.
    Li J, Zhang J J, Zhao X J, et al. Preparation of porcine hemoglobin microcapsules of chitosan-sodium alginate. Frontiers of Chemistry in China, 2007, 2(3): 315–317CrossRefADSGoogle Scholar
  4. 4.
    Nunthanid J, Laungtana-anan M, Sriamornsak P, et al. Characterization of chitosan acetate as a binder for sustained release tablets. Journal of Controlled Release, 2004, 99(1): 15–26PubMedCrossRefGoogle Scholar
  5. 5.
    Mo X M, Chen Z G, Hans J W. Electrospun nanofibers of collagen-chitosan and P(LLA-CL) for tissue engineering. Frontiers of Materials Science in China, 2007, 1(1): 20–23CrossRefGoogle Scholar
  6. 6.
    Wang L C, Chen X G, Yu L J, et al. Controlled drug release through carboxymethyl-chitosan/poly(vinyl alcohol) blend films. Polymer Engineering and Science, 2007, 47(9): 1373–1379CrossRefGoogle Scholar
  7. 7.
    Guo T Y, Xia Y Q, Hao G J, et al. Adsorptive separation of hemoglobin by molecularly imprinted chitosan beads. Biomaterials, 2004, 25(27): 5905–5912PubMedCrossRefGoogle Scholar
  8. 8.
    Barreiro-Iglesias R, Coronilla R, Concheiro A, et al. Preparation of chitosan beads by simultaneous cross-linking/insolubilisation in basic pH rheological optimisation and drug loading/release behaviour. European Journal of Pharmaceutical Sciences, 2005, 24(1): 77–84PubMedCrossRefGoogle Scholar
  9. 9.
    Mi F L, Tan Y C, Liang H C, et al. In vitro evaluation of a chitosan membrane cross-linked with genipin. Journal of Biomaterials Science, Polymer Edition, 2001, 12(8): 835–850CrossRefGoogle Scholar
  10. 10.
    Blanco MD, Gómez C, Olmo R, et al. Chitosan microspheres in PLG films as devices for cytarabine release. International Journal of Pharmaceutics, 2000, 202(1–2): 29–39PubMedCrossRefGoogle Scholar
  11. 11.
    Shu X Z, Zhu K J. Chitosan/gelatin microspheres prepared by modified emulsification and ionotropic gelation. Journal of Microencapsulation, 2001, 18(2): 237–245PubMedCrossRefGoogle Scholar
  12. 12.
    Zhou HY, Chen XG, Liu C S, et al. Chitosan/cellulose acetate microspheres preparation and ranitidine release in vitro. Pharmaceutical Development and Technology, 2005, 10(2): 219–225PubMedCrossRefGoogle Scholar
  13. 13.
    Makhija S N, Vavia P R. Controlled porosity osmotic pumpbased controlled release systems of pseudoephedrine I. Cellulose acetate as a semipermeable membrane. Journal of Controlled Release, 2003, 89(1): 5–18PubMedCrossRefGoogle Scholar
  14. 14.
    Lu E X, Jiang Z Q, Zhang Q Z, et al. A water-insoluble drug monolithic osmotic tablet system utilizing gum arabic as an osmotic, suspending and expanding agent. Journal of Controlled Release, 2003, 92(3): 375–382PubMedCrossRefGoogle Scholar
  15. 15.
    Santus G, Baker R W. Osmotic drug delivery: a review of the patent literature. Journal of Controlled Release, 1995, 35(1): 1–21CrossRefGoogle Scholar
  16. 16.
    Shigemasa Y, Matsuura H, Sashiwa H, et al. Evaluation of different absorbance ratios from infrared spectroscopy for analyzing the degree of deacetylation in chitin. International Journal of Biological Macromolecules, 1996, 18(3): 237–242PubMedCrossRefGoogle Scholar
  17. 17.
    El-Gibaly I. Development and in vitro evaluation of novel floating chitosan microcapsules for oral use: comparison with non-floating chitosan microspheres. International Journal of Pharmaceutics, 2002, 249(1–2): 7–21PubMedCrossRefGoogle Scholar
  18. 18.
    Bayomi M A, Al-Suwayeh S A, El-Helw A M, et al. Preparation of casein-chitosan microspheres containing diltiazem hydrochloride by an aqueous coacervation technique. Pharmaceutica Acta Helvetiae, 1998, 73(4): 187–192PubMedCrossRefGoogle Scholar
  19. 19.
    Chapman S R, Rowe R C, Newton J M. Characterization of the sphericity of particles by the one plane critical stability. Journal of Pharmacy and Pharmacology, 1988, 40(7): 503–505PubMedGoogle Scholar
  20. 20.
    Gupta K C, Ravi Kumar M N V. Drug release behavior of beads and microgranules of chitosan. Biomaterials, 2000, 21(11): 1115–1119PubMedCrossRefGoogle Scholar
  21. 21.
    Lucke A, Fustella E, Teszmar J, et al. The effect of poly(ethylene glycol)-poly(D,L-lactic acid) diblock copolymers on peptide acylation. Journal of Controlled Release, 2002, 80(1–3): 157–168PubMedCrossRefGoogle Scholar
  22. 22.
    Wu T M, Wu C Y. Biodegradable poly(lactic acid)/chitosanmodified montmorillonite nanocomposites: Preparation and characterization. Polymer Degradation and Stability, 2006, 91(9): 2198–2204CrossRefGoogle Scholar
  23. 23.
    Freier T, Koh H S, Kazazian K, et al. Controlling cell adhesion and degradation of chitosan films by N-acetylation. Biomaterials, 2005, 26(29): 5872–5878PubMedCrossRefGoogle Scholar
  24. 24.
    Brouwer J, Leeuwen-Herberts T V, Ruit M O V D. Determination of lysozyme in serum, urine, cerebrospinal fluid and feces by enzyme immunoassay. Clinica Chimica Acta, 1984, 142(1): 21–30CrossRefGoogle Scholar
  25. 25.
    Porstmann B, Jung K, Schmechta H, et al. Measurement of lysozyme in human body fluids: comparison of various enzyme immunoassay techniques and their diagnostic application. Clinical Biochemistry, 1989, 22(5): 349–355PubMedCrossRefGoogle Scholar
  26. 26.
    Brugnerotto J, Lizardi J, Goycoolea F M, et al. An infrared investigation in relation with chitin and chitosan characterization. Polymer, 2001, 42(8): 3569–3580CrossRefGoogle Scholar
  27. 27.
    Al-Ahmed A, Mohammad F, Rahman M Z A. Composites of polyaniline and cellulose acetate: preparation, characterization, thermo-oxidative degradation and stability in terms of DC electrical conductivity retention. Synthetic Metals, 2004, 144(1): 29–49CrossRefGoogle Scholar
  28. 28.
    Agatonovic-Kustrin S, Rades T, Wu V, et al. Determination of polymorphic forms of ranitidine-HCl by DRIFTS and XRPD. Journal of Pharmaceutical and Biomedical Analysis, 2001, 25(5-6): 741–750PubMedCrossRefGoogle Scholar
  29. 29.
    Nair R, Nyamweya N, Gönen S, et al. Influence of various drugs on the glass transition temperature of poly(vinylpyrrolidone): a thermodynamic and spectroscopic investigation. International Journal of Pharmaceutics, 2001, 225(1-2): 83–96PubMedCrossRefGoogle Scholar
  30. 30.
    Selvaraj V, Alagar M, Hamerton I. Analytical detection and biological assay of antileukemic drug using gold nanoparticles. Electrochimica Acta, 2006, 52(3): 1152–1160CrossRefGoogle Scholar
  31. 31.
    Lin WC, Yu D G, Yang MC. pH-Sensitive polyelectrolyte complex gel microspheres composed of chitosan/sodium tripolyphosphate/dextran sulfate: swelling kinetics and drug delivery properties. Colloid Surface B: Biointerfaces, 2005, 44(2–3): 143–151CrossRefGoogle Scholar

Copyright information

© Higher Education Press and Springer-Verlag GmbH 2008

Authors and Affiliations

  1. 1.The Chemical Engineering & Pharmaceutics CollegeHenan University of Science and TechnologyLuoyangChina
  2. 2.College of Marine Life ScienceOcean University of ChinaQingdaoChina

Personalised recommendations